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EVENTS RELATED TO THE PHAGOCYTOSIS OF CRYPTOCOCCUS 
NEOFORMANS BY ALVEOLAR MACROPHAGES
CHAPTER I 
INTRODUCTION AND LITERATURE REVIEW
Cryptococcosis is a subacute or chronic human in­
fection caused by the yeast Cryptococcus neoformans. The 
organism has a pronounced predilection for the central ner­
vous system, although it may cause a subacute or chronic 
infection of the skin, lungs, or other parts of the body.
A complete and accurate review of the literature concerning 
the history of cryptococcosis has been presented by Price 
(1971).
Several years ago Bulmer and co-workers started an 
investigation of the pathogenesis of cryptococcosis. These 
studies began with work on the properties of C. neoformans, 
which make it a pathogen and evolved into studies of host 
defense mechanisms against the invading organisms (Bulmer, 
Sans, and Gunn, 1967; Bulmer and Sans, 1967; Bulmer and Sans, 
1968; Farhi, Bulmer, and Tacker, 1970; Tacker, Farhi, and 
Bulmer, 1972).
For several years, it has been assumed that the res­
piratory tract is the portal of entry in man for Cryptococcus 
neoformans. This assumption has been based, mainly, on re­
ported cases of primary pulmonary cryptococcosis and on iso­
lation of the organisms from soils and bird droppings from 
which it can be aerosolized (Powell, Dahl, Weeks, and Tosh, 
1972; Smith, Ritter, Larsh, and Furcolow, 1964; Ritter and 
Larsh, 1963; Khan, Myers, and Koshy, 1959; Taylor, 1970; 
Emmons, 1955; Litman and Zimmerman, 1956; Kao and Schwarz, 
1957). If one assumes these data to be valid, then it be­
comes of interest to learn more about the fate of organisms 
which lodge in the lungs. To do this, one must consider the 
elements of the lung and how the lung is able to clear it­
self of the foreign material.
Because pulmonary macrophages engulf inhaled dust 
particles and can often be identified in the sputum as car­
riers of inhaled, insoluble foreign materials, they have long 
been considered an integral component of the pulmonary clear­
ance mechanism. Yet, recognition of the fact that pulmonary 
macrophages may be specific entities and may play a specific 
role in host defense mechanisms is relatively recent.
The importance of pulmonary macrophages as a lung 
clearance mechanism was reaffirmed by the publications of La 
Belle and Brieger (1959, 1960) . They found that the amount 
of dust eliminated from the lungs during the early post­
exposure period was proportional to the numbers of free
phagocytic cells present in a saline lavage of the lungs, 
and to the number of phagocytes visible in lung sections per 
unit area. The authors concluded that "transport of de­
posited particulates by phagocytes is the primary mechanism 
by which inhaled dust particles are eliminated from the 
lung."
Myrvik, Leake and Fariss (1961 b) were able to col­
lect large numbers of rabbit alveolar mononuclear cells 
which resembled macrophages and which were capable of phago- 
cytizing particulate material dm vitro. Cell free extracts 
were prepared by alternate freezing and thawing or by sonic 
oscillation. The extracts contained large amounts of lyso- 
zyme (2,000 to 4,000 ug/ml of packed cells), which indicated 
that the cells might be different from other monocytes. The 
authors also suggested, based on their high state of purity 
(less than 1 per cent polymorphonuclear cells), that these 
cells were the "normal scavenger flora of the lower respi­
ratory tract."
At about the same time that Myrvik, Leake and Fariss 
(1961 a) reported a metabolic difference between alveolar 
macrophages and other white blood cells, the excellent review 
by Karnovsky (1962) was published. Until that time, very 
little information was known concerning the metabolic basis 
of phagocytosis in mammalian phagocytic cells, other than in 
polymorphonuclear cells and in monocytes. Karnovsky (1962) 
also made a comparison using guinea pig polymorphonuclear
leucocytes and monocytes (obtained from the peritoneum), of 
metabolic activity during phagocytosis. In addition, in­
formation on the metabolic activity of lung macrophages was 
obtained. The metabolic results may be summarized as fol­
lows: Polymorphonuclear leucocytes, monocytes, and alveolar
macrophages have a "resting" uptake of oxygen of approxi­
mately 2.5, 7.5, and 30 p1/hr/mg protein, respectively. Res­
piration of polymorphonuclear leucocytes, monocytes, and 
alveolar macrophages increases about 2.5 fold, 3.5 fold, and 
only 20 per cent respectively, during phagocytosis. Using 
glucose labeled in carbon-1 or carbon-6, the ratio (C1:C6) 
of counts appearing in expired CO2 of polymorphonuclear 
leucocytes increased from a value of 8, at rest, to 22. With 
monocytes, the ratio at rest is rather high (approximately 
20) and is unchanged by phagocytosis. The ratio for alve­
olar macrophages is also unchanged by phagocytosis, remain­
ing about 8, with the appearance of label in the CO2 from 
each type of labeled glucose: In other words phagocytosis
caused an increase of less than 20 per cent which was pro­
portional to aforementioned oxygen uptake. The influence of 
various metabolic inhibitors on the three types of phago­
cytes was of considerable interest. The principle observa­
tion was that phagocytosis in all of the cell types is 
inhibited by iodoacetate and fluoride (inhibitors of gly­
colysis) . Anaerobiosis, cyanide, and dinitrophenol affect 
only phagocytosis by alveolar macrophages. These cells are.
therefore, apparently dependent on oxidative energy meta­
bolism for phagocytic function. This is a particularly 
important observation because it reflects a basic difference 
between alveolar macrophages and other leucocytes. It ap­
parently represents a phenotypic difference and one could 
easily imagine a genotypic variation based on the knowledge 
of different metabolic pathways controlled by specific genes.
Further evidence that alveolar macrophages are dif­
ferent from other macrophages comes from the work of Myrvik, 
and others (1961 a,b), and Leake, Gonzeler-Ojeda, and 
Myrvik (1964) . In 1961, these workers obtained alveolar 
macrophages and oil-induced peritoneal macrophages from 
rabbits and examined them quantitatively for lysozyme, acid 
phosphatase and beta glucuronidase. The extracts from alve­
olar macrophages contained 2-5 times higher concentrations 
of the three enzymes than those from oil-induced peritoneal 
macrophages. For example, the average lysozyme level for 
alveolar macrophages was approximately 2800 yg/ml packed 
cells, whereas the peritoneal cells contained about 600 yg/ml 
packed cells. Pavillard (1963), in a separate study involv­
ing rats, supported the observations of Myrvik, et He
also found that acid phosphatase and lysozyme levels were 
considerably higher in alveolar macrophages as compared with 
peritoneal macrophages.
The alveolar macrophage is at least quantitatively 
different in enzymatic content from other macrophages. It
also seems to engage in oxygen dependent metabolism, whereas 
peritoneal monocytes may be facultative with respect to 
oxygen requirements. A question then arises as to the origin 
of alveolar macrophages. It is important to know whether 
phagocytes with the characteristics mentioned before arise 
from the lung tissues and cells or whether they come from the 
peripheral blood, acquiring their special nature once they 
arrive. The answers to these questions are still being 
sought. Many of the early investigators were convinced that 
alveolar macrophages originate from the lung itself (Leake, 
Gonzeler-Ojeda, and Myrvik, 1964). Textbooks of histology 
usually either imply that alveolar macrophages can come from 
the lung or they provide inconclusive information. More re­
cently, some investigators have considered both theories of 
origin (Cohn, 1968). Pinkett, Cowdrey, and Nowell (1966), 
using karyotypic markers, found that at least 50 per cent of 
the alveolar macrophages come from the peripheral circu­
lation. In general, the use of karotypes for the study of 
mononuclear phagocytic kinetics has the deficiency of not 
allowing for examination of the morphology of the cell in de­
tail and of depending on the mitotic activity iji situ, which 
in many instances is quite low.
Normally, inhaled bacteria disappear rapidly from 
the lungs of experimental animals. This early clearance of 
bacteria is thought to be an important process in non-speci­
fic resistance to infection in the bronchopulmonary tree. A
wide variety of chemical, hormonal, and environmental agents 
depress, to varying degrees, the rate at which inhaled via­
ble bacteria disappear from the lungs. Such studies support 
epidemiologic evidence that multiple agents may be involved 
in the pathogenesis of chronic infections of the lungs.
It is not clear, however, to what extent each of the 
several components of the bronchopulmonary tree participates 
in the initial inactivation of inhaled bacteria. Although 
the mucociliary stream is frequently credited with this 
cleansing action, much evidence suggests that bacterial 
clearance may be accomplished by alveolar macrophages.
In light of the higher enzymatic activity in alve­
olar macrophages (particularly lysozyme), one might assume 
that they would be able to dispose of microorganisms ef­
fectively. Pavillard (1963), however, presented data show­
ing that alveolar macrophages are less able to kill Esche­
richia coli and Staphylococcus aureus in vitro than are 
peritoneal macrophages which presumably have lower levels of 
enzymes to deal with these bacteria. It is important to 
remember, however, that it is still not known whether lyso­
somal enzymes play a role in the bactericidal activity of 
macrophages. If they do not, then one would have to attach 
more importance to the mucociliary stream. Yet, studies by 
Green and Kass (1964) and Green (1968) again point to the 
lung macrophage as the major factor of early resistance to 
bacterial infection. When mice were exposed to an aerosol
8of 32p_tagged S . aureus and Proteus mirabilis and the rate 
of decline of bacterial viability was compared with the rate 
of their mechanical removal, it was found that bacterial 
viability declined 80 to 90 per cent in 4 hours, whereas 
radioactivity declined by only 14 to 20 per cent. The marked 
disparity in these rates indicated to these workers that 
mechanical removal comprised a relatively small fraction of 
the total clearing process. They also stated that "the in 
situ bactericidal action of the lung predominated over the 
mechanical removal process in achieving clearance of the in­
haled bacteria." Another interesting observation relating to 
bactericidal activity of alveolar macrophages comes from the 
work of Leake and Myrvik (1964) . They found that subcellular 
particles of rabbit alveolar macrophages containing lysozyme, 
cathepsin, and acid phospatase were resistant to osmotic 
shock and that lysozyme was released only when electrolyte 
(0.15 M NaCl) was added to the system. This is in contrast 
to the particles of peritoneal macrophages which were very 
susceptible to osmotic shock. These findings could lead one 
to the conclusion that the alveolar macrophages do not re­
lease their lysosomal contents readily. This conclusion would 
tend to support the results of Pavillard (1963) , but not those 
of Green and Kass (1964, 1968). This seems rather confusing, 
however one must remember that there is a difference between 
clearance and intracellular death. It is quite possible that 
the majority of organisms phagocytized by alveolar macro­
phages are simply transported via the phagocytes to the muco­
ciliary stream and washed out in expelled air. If one con­
siders the diverse virulence factors of bacteria, it is 
understandable why a given organism may be killed by phago­
cytic cells and others are not. In other words, it is to be 
expected that the ability of phagocytes to kill organisms 
depends on factors quite distinct from their ability to 
transport particulate material mechanically to the muco­
ciliary stream. Both factors are important, however, since 
the pathogenesis of infectious disease depends, in general, 
on the presence of viable organisms.
It now seems appropriate to review some of what is 
known about intracellular killing of phagocytized microbes. 
The mechanisms involved in intracellular killing of phago­
cytized microorganisms have been the subject of a consider­
able amount of investigation.
Ever since Metchnikoff's original work demonstrating 
phagocytosis by certain leucocytes, man has sought an ex­
planation for the antibacterial nature of these body com­
ponents. Most common bacteria engulfed by neutrophils are 
rapidly killed. A few microorganisms, such as tubercle 
bacilli, brucellae, and Histoplasma capsulatum, are not sus­
ceptible to killing by neutrophils. Death of microorganisms 
soon after their engulfment by neutrophils has been estab­
lished by many different techniques, perhaps the most direct 
and elegant being those of Wilson, Wiley, and Bruno (1957).
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Mixtures of leucocytes and streptococci were observed and 
photographed under phase contrast microscopy in thin cover 
slip preparations. At various time intervals following 
phagocytosis, neutrophils were disrupted, without damage to 
the bacteria, by passing an electric current through the 
preparations. Observations were continued for several hours 
to determine if streptococci liberated from leucocytes were 
capable of growth. Streptococci which had resided inside 
the neutrophils for less than five minutes almost always sur­
vived and grew, whereas those which had been within neutro­
phils for 15 minutes or longer were usually dead.
Of the various intraphagocytic substances which might 
be involved in bactericidal activity, ordinary digestive 
enzymes such as proteinases, cannot be held entirely respon­
sible, since bacteria generally thrive in the presence of 
these materials (Salton, 1953). Numerous antimicrobial sub­
stances such as peroxide, leukins, and phagocytin have been 
found in neutrophils and warrant further consideration, even 
though it is not yet established whether they are active in 
vivo.
Phagocytic neutrophils produce large quantities of 
lactic acid in the course of their glycolytic metabolism. 
Studies employing indicator vital dyes, or the introduction 
of micro-electrodes, indicated that the pH surrounding en­
gulfed particles may be as low as 3.0 to 5.0 (Cohn and 
Morse, 1960). This degree of acidity, especially in the
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presence of organic acids, could be lethal to many types of 
microorganisms. Acidity of the phagocytic vacuole, like the 
acidity of the stomach juices in man, may exert an anti­
microbial effect. Acid alone cannot, however, account com­
pletely for microbial death in neutrophils. Many bacteria 
which can survive at acid pH, for example certain coliforms, 
are rapidly killed in these cells.
Lysozyme, an aminopolysaccharidase discovered by 
Fleming and Allison (1922), is present in large amounts in 
neutrophils (approximately 2.0 mg of lysozyme per gram wet 
weight of packed cells) and, furthermore, it is associated 
with the cytoplasmic granules. Lysozyme degrades the cell 
wall and causes lysis of certain species of bacteria and, 
in conjunction with other agents such as acid, cation che­
lators or antibody and complement (Tagashira, et al., 1953), 
kills other types of microorganisms as well. Whether lyso­
zyme behaves in neutrophils primarily as an antibacterial 
agent or as a digestive enzyme remains to be established. 
Perhaps both activities are operative, at least in some 
situations.
Antimicrobial basic proteins and peptides, usually 
called "leukins," have been extracted from neutrophils 
(Skarnes and Watson, 1956). Their suppressive effect on 
microorganisms is not disputed, but reasonable doubt exists 
as to their occurrence in the living cell at sites acces­
sible to contact with ingested bacteria.
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Hirsch (1956) has extracted from neutrophils of 
various animal species a bactericidal substance called 
"phagocytin." This material has never been purified, but 
its behavior is consistent with that of a basic protein.
Very low concentrations, less than 1.0 ug/ml of the crude 
phagocytin preparations, promptly kill a wide range of 
microorganisms without lysing them; the mechanism of its 
action is not known.
Until about 1965, it was known only that degranu­
lation of polymorphonuclear leucocytes occurred during or 
after phagocytosis. Because of the work of Hirsch and Cohn 
(1960) and Hirsch (1962), it is known that bacteria ingested 
by neutrophils do not lie free in the cytoplasm but, rather, 
are contained in a pouch formed by cell membrane invagination 
during phagocytosis. Similarly, digestive enzymes and anti­
microbial substances of the neutrophils are not dissolved in 
the cytoplasm, but are confined within membrane bound 
granules referred to as "lysosomes." When the membrane of 
the granules and that surrounding the ingested particle come 
into contact, they apparently fuse with resulting discharge 
of lysosomal contents directly into the phagocytic vesicle. 
The resulting structure has been called the "phagolysosome" 
by de Duve and Wattiaux (1966). Thus, neutrophil engulfment 
and digestion are similar in many respects to that in higher 
multicellular organisms (man and animals); the cell ingests 
particulate matter (food) in a vesicle rather than into the
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surrounding cytoplasm. This mechanism provides a means for 
controlled granule lysis and, furthermore, probably explains 
how the neutrophil can degrade engulfed material without, at 
the same time, digesting its own cytoplasm and nuclear 
structures.
Even though many facts concerning phagocytosis at the 
cellular and subcellular level have been uncovered, the 
specific mechanism causing intraphagocytic death of ingested 
organisms is still unknown. A step toward understanding this 
mechanism has come to light slowly during the last two de­
cades. An enzyme, isolated and purified from subcellular 
components, has been discovered which has potent antimi­
crobial properties. The enzyme has been called "myeloperoxi­
dase." Originally, "verdoperoxidase" was isolated and 
partially purified by Agner (1941). Shortly thereafter, the 
name was changed to myeloperoxidase because investigators 
were able to extract large quantities of it from leucocytes 
of patients with myeloid leukemia. The importance of the 
enzyme was probably not realized until Klebanoff and Luebke's 
work was published in 1965 (Klebanoff and Luebke, 1965) .
These workers were investigating the antibacterial proper­
ties of bovine saliva and found the peroxidase activity to 
be high. Also, they found a dialyzable component which was 
identified as a thiocyanate ion. Hydrogen peroxide was also 
noted to be present in significant amounts. When the three 
components (salivary peroxidase, thiocyanate ion and H 2 O2 )
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were combined ^  vitro, they effectively killed Lactobacillus 
acidophilus. The authors also found that bovine milk had 
large quantities of lactoperoxidase. Morrison and Allen 
(1963), a short time before, had shown that lactoperoxidase 
from bovine milk was immunelogically indistinguishable from 
bovine salivary peroxidase.
At about the same time, Reiter, Pickering, Oram and 
Pope (1963) showed that the antimicrobial system of milk re­
quires thiocyanate ions in addition to lactoperoxidase, and 
they suggested that the milk and saliva antimicrobial systems 
may be similar. In the studies mentioned previously, hydro­
gen peroxide was not incorporated, however catalase added to 
the antimicrobial system prevented inhibition of growth of 
Lactobacillus acidophilus. This was prima facia evidence for 
the conversion of ^2^2 water. Realizing the fore­
going facts, Klebanoff, Clem and Luebke (1966) tested the 
antimicrobial properties of the lactoperoxidase-thiocyanate- 
H 2 O 2 system. He was able to show killing of various micro­
organisms under test conditions. Moreover, myeloperoxidase 
from canine PMN's could substitute for the lactoperoxidase 
of bovine milk. When catalase was added to the system, 
microbial killing was prevented, indicating that hydrogen 
peroxide was an important component. Later, it was shown 
that several halides, in the proper concentration, could 
substitute for the thiocyanate ion (Klebanoff, 1967 a; 
Klebanoff, 1967 b).
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Agner (1941) estimated the peroxidase content of 
human myeloid leukemic leucocytes to be about 1-2 per cent 
of the dry weight of these cells, whereas Schultz and 
Kaminker (1962) suggested that the normal human neutrophil 
has a peroxidase content of greater than 5 per cent of the 
dry weight. In 1967, Klebanoff (1967 b) undertook another 
study of the bactericidal activity of myeloperoxidase (MPO). 
This time he replaced the thiocyanate ion with iodide in 
the MPO system. ^  vitro he noted that the MP0-iodide-H202 
system was effective in killing E. coli and that the indi­
vidual components lacked bactericidal activity.
Iodide ions are readily oxidized by peroxidase and 
H 2 O 2 to iodine, a known antimicrobial agent (Klebanoff, Yip, 
and Kessler, 1962; Taurog and Gamble, 1966). The first 
assumption of the former authors was that the antibacterial 
effect of the system was due to the accumulation of iodine 
in the reaction mixture. Thirty minutes of preincubation of 
MPO system components without the addition of E. coli caused 
production of iodine. When E. coli was added to the pre- 
incubated products, no killing of the organisms was observed. 
Clearly, the organism must be present in the MPO reaction 
mixture for the peroxidase system to be effective.
Apparently, myeloperoxidase catalyzes the formation 
the iodine-carbon bonds when incubated with iodide ion, 
hydrogen peroxide and a suitable iodine acceptor such as 
tyrosine or tyrosine residues of proteins (Klebanoff, Yip,
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and Kessler, 1962; Taurog and Gamble, 1966). A character­
istic of the iodination reaction catalyzed by peroxidase is 
that the iodine acceptor must be present in the reaction 
mixture during iodide oxidation for optimum iodination. The 
similarity to the bactericidal effect of myeloperoxidase- 
iodide-H2 0 2  in this regard is striking.
Now that it is known that the MPO-system operates in 
vitro , one must ask if the system can be applied vivo.
First, are the concentrations of the substances required for 
the MPO-system to operate present ^  vivo? It has already 
been shown that myeloperoxidase is present in high concentra­
tions within neutrophils (Agner, 1941; Schultz and Kaminker, 
1962). Moreover, histochemical studies suggest its locali­
zation in the cytoplasmic granules of the cell (Kaplow, 1965). 
As mentioned before, the lysosomal granules of the neutrophil 
rupture after phagocytosis and discharge of their contents 
into the phagocytic vacuole containing ingested microorgan­
isms or particles. This occurs both vitro and vivo 
(Hirsch and Cohn, 1960; Hirsch, 1962).
Iodide is present in very low concentration in plasma 
(0.1-0.6 yg/100 ml plasma) (Todd-Sanford, 1969). However, 
the uptake of iodide by normal human leucocytes has been re­
ported to be 1200 times the uptake by red blood cells (Siegel 
and Sachs, 1964). Thyroxine and triiodothyronine also are 
preferentially taken up by leucocytes and the iodination of 
the hormones by leucocyte preparations has been reported by
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Kurland, Krotkov, and Freedberg (1960).
It has been reported that ^2^2 formed in the PMN 
during the period of accelerated metabolism following phago­
cytosis (Iyer, Islam, and Quastel, 1961; Karnovsky, 1962) . 
Recently, the alveolar macrophage has been noted also to have 
an increased production of ^2^2 ^ secondary event to
particle entry (Bernard, Gee, Vassallo, Bell, Kaskin, Basford, 
and Field, 1970).
Apparently, all the components for the intracellular 
in vivo MPO-system are found within the neutrophil, at least 
in the PMN. Klebanoff and Luebke (1965) have shown that for 
a bactericidal reaction to occur within the MPO-system the 
pH must be around 5.0. The intracellular pH in the vicinity 
of the ingested particle has been reported to be distinctly 
acid, i.e., in the vicinity of the pH optimum for the iodi­
nation reaction. The low pH is, presumably, due to the for­
mation of lactic acid (Karnovsky, 1962) .
Even though there is good evidence that iodide may 
be the significant halide ion active vivo, there remains 
some doubt. Accordingly, Klebanoff (1968) sought other 
halide ions that might be more readily available to the PMN 
in vivo. Essentially, Klebanoff found that bromide and 
chloride, but not fluoride could be substituted for iodide 
in the MPO-system. It should be noted, however, that the 
halides are not equally effective. In a controlled system 
containing 5 x 10^ E. coli/ml, acetate buffer (pH 5.0) , and
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150 o-dianisidine units, it required 1.0 viM of chloride and 
0 . 1  uM of bromide to kill all the E. coli, whereas it re­
quired only 0 . 0 1  viM of iodide to kill the same number of 
organisms.
In general, however, Klebanoff (1968) found that the 
properties of the myeloperoxidase-bromide-H2 0 2  or chloride- 
H 2 O 2 , bactericidal system was similar to those described 
previously for the iodide containing system. The deletion 
of any component (MPO, H 2 O 2 , bromide or chloride ions) from 
the reaction mixtures greatly decreased the bactericidal 
effect. He also noted that preheating the myeloperoxidase 
for 10 minutes at 90° destroyed its bactericidal effect.
The finding that chloride ions could be substituted 
for iodide was of great interest. Chloride ions are readily 
taken up by leucocytes. The average intracellular chloride 
concentration of rabbit peritoneal lavage leucocytes is 93 
meq/kg. of cell water as compared to normal rabbit serum con­
centration of 115 meq/liter of serum water (Wilson and Manery, 
1949). Klebanoff (1968) reported that a bactericidal effect 
was observed in the MPO-system at a chloride ion concentra­
tion of 0.005 meq/liter. This appears to be well within the 
concentration limits reported to be present in leucocytes.
Presently, most workers believe that the MPO-system 
is indeed a significant bactericidal mechanism associated 
with phagocytes and phagocytosis. Yet, the picture remains 
unclear mainly because no one is sure just how the MPO-system
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effects killing. Moreover, there is at present a major 
controversy over which halide ion actually takes part in the 
MPO-system. As in the past, it remains difficult to compare 
results of different investigators because different methods 
were employed. More recent work concerning the biochemical 
mechanisms of the bactericidal activities of phagocytosis 
will be presented in the Discussion.
The purpose of this research was to examine the events 
pertaining to the phagocytosis of C. neoformans by alveolar 
macrophages. This included such events as intracellular fate, 
resistance to phagocytosis and mechanisms involved in intra­
cellular degradation or dispersal.
CHAPTER II 
MATERIALS AND METHODS 
Organisms
Both a non-encapsulated and an encapsulated strain 
of Cryptococcus neoformans (strain CIA) were used in these 
studies. The following fungi were also utilized in connec­
tion with various experiments undertaken in the study; 
Sporotrichum schenckii, Candida albicans, Aspergillus niger, 
and Rhizopus oryzae. All of the fungi were obtained from 
the stock collection in the Department of Microbiology and 
Immunology, University of Oklahoma Health Sciences Center, 
Oklahoma City, Oklahoma. Three bacteria, Escherichia coli, 
(ATCC 11775), Salmonella typhosa and Seratia marcescens, 
were also used in this study.
Animals
Adult male and female Hartley strain guinea pigs 
were used throughout the study as the source of alveolar 
macrophages for the vivo isotope experiments, and for the 
production of activated macrophages.
Media
Non-encapsulated cells of Cryptococcus neoformans were 
grown on a synthetic low pH medium (LpH) . This medium was
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prepared as follows: Essential salt solution (ESS) con­
sisted of 100 ml of distilled water containing KH2 PO4 , 2.0 
gm; CaCl2 ’2 H 2 0 , 0.002 gm; (NH4 ) 2 SO4 , 2.0 gm; MgCl*6 H 2 0 ,
0.2 gm; FeCl2 *4H 2 0 , 0.04 gm; MnCl2 *4 H 2 0 , 0.0015 gm; and 
NaN0 3 , 0.0015 gm. LpH agar medium was prepared by adding 
0.02 gm/ml glucose and 5.0 yg/ml thiamine monochloride to a 
1:10 dilution of ESS and 2.0 per cent agar (Difco). Hydro­
chloric acid (O.lN) was used to adjust the pH to 4.5-5.0.
Growth Media for Aerosolization 
and 32p incorporation
Bacto-Yeast Nitrogen Base without Amino Acids (Difco) 
was used in the first experiments. The pH was adjusted 5.0 
with O.lN HCl.
In ar. attempt to find a liquid medium that would 
produce C. neoformans with desirable characteristics as to 
cell size and abundance of growth, variations of Basic Czapek 
(Difco) medium were utilized. Modifications included the 
additions of varying amounts of glucose, NaN0 3  and K 2 HPO4 , 
the latter as a source of extrinsic phosphate ions. Czapek 
(Difco) medium contains: MgS0 4 , 0.5 gm/1000 ml; KCl, 0.5
gm/1000 ml; FeS0 4 , 0*01 gm/1000 ml; peptone, 5.0 gm/1000 ml; 
yeast extract, 1.0 gm/1000 ml. In later experiments, Czapek 
medium was prepared without peptone and yeast extract. Pep­
tone and yeast extract and/or glucose were added according 
to the growth and size of the C. neoformans. Also, K 2 HPO4
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(range, 0-150 mg/100 ml) were added to Czapek medium in an 
effort to control size and growth of the organisms. All of 
these solutions were adjusted to pH 5.0 with O.lN HCl.
Radioactive Labeled Organisms. Depending on the 
particular experiment, two 250 ml flasks were inoculated with
2.0 X 10® nonencapsulated C. neoformans which had been 
starved for 48.0 hours in a pH 7.0 tris buffer. One or two 
microcuries of in 0.02N HCl was added to each flask
of modified Czapek medium and organisms. The cultures were 
placed on a mechanical shaker and incubated at room tempera­
ture. After 5 days incubation the organisms were harvested 
by centrifugation and washed 4 times in a pH 5.0 acetate buf­
fer. Next, the washed, radioactive organisms were resuspended 
in one of the aforementioned media and counted microscopi­
cally using a hemacytometer. Samples of the organisms were 
dilution plated to determine the viability.
Alveolar Macrophages
Guinea pig alveolar macrophages were harvested by a 
modification of the method of Myrvik, Leake and Fariss (1961 
b) .
Under aseptic conditions, a midline incision was 
made in the thoracic area which extended from the cephalic 
part of the trachea downward to the xiphoid process. Next, 
the trachea was dissected out and clamped. This caused death 
of the animal and prevented backwash of normal microbial flora
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from the posterior pharynx. Quickly, the intact lungs and 
trachea were removed from the thoracic cavity and washed 
vigorously with sterile 0.85 per cent NaCl. Next, the lungs 
were filled, via the trachea, with cold, sterile Eagle's 
balanced salt solution (BSS). The trachea was again clamped 
and the fluid-filled lungs were gently massaged, under 
sterile conditions, for about 2 minutes. The clamp on the 
trachea was removed and the Eagle's solution containing the 
alveolar macrophages was allowed to flow, by gravity, into 
15 ml sterile, siliconized centrifuge tubes. The first wash­
ing from the lungs was discarded because it contained pre­
dominantly the so-called "dust cells" (alveolar macrophages 
that are metabolically in death phase and containing dust 
particles), and other cellular debris. The cells obtained 
from subsequent washings were washed 3 times in Eagle's BSS 
at a centrifuge speed not exceeding 400 x g. After the final 
centrifugation, the alveolar macrophages cells were resus­
pended in cold Eagle's BSS, counted and stained with 1 per 
cent trypan blue to determine viability.
In Vitro Phagocytosis and Fate
In order to obtain maximum percentage phagocytosis 
in vitro with alveolar macrophages it was necessary to study 
various physical and biological conditions of the system.
To determine if autologous serum had an influence on 
phagocytosis, several experiments were tried in which the
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serum concentration was varied from 0-65 per cent. At the 
same time, it was necessary to determine the optimal ratio 
of yeast cells (C. neoformans-strain CIA) to alveolar macro­
phages. LpH cells (nonencapsulated) were incubated in 100 x 
13 mm siliconized test tubes with the guinea pig alveolar 
macrophages at 37° C on a rotator (30 rpm) for 2 hours. 
Samples were removed at 15, 30, 60 and 120 minutes incuba­
tion and scored for percentage phagocytosis by microscopic 
examination of stained cells. This phagocytic procedure was 
employed for each experiment where there was a variation in 
the yeast cell ratio and the percentage serum. All ratio 
experiments consisted of an average of 5 separate determina­
tions. Thirty per cent autologous serum was used in the 
ratio experiments. One hundred alveolar macrophages were 
counted and the number of alveolar macrophages containing 
cryptococcal cells was recorded as the percentage phagocy­
tosis. The phagocytic index was determined by enumerating 
the average number of yeast cells ingested per 1 0 0  alveolar 
macrophages.
In some instances, purified capsular material was 
added to the system to see if it had any effect on phagocy­
tosis by the alveolar macrophages.
In vitro intracellular fate experiments were per­
formed after the optimal conditions of phagocytosis had been 
determined. Fate experiments were similar to the phagocy­
tosis procedure except for certain experimental modifica­
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tions. The individual cryptococcus-serum suspensions were 
dispensed, 0.5 ml per tube (6 x 10® cells/ml), into two sets 
of siliconized test tubes (100 x 15 mm). To each tube in set 
1, 0.5 ml of freshly collected alveolar macrophages was 
added (2 . 0  x 1 0 ® alveolar macrophages/ml), making the ratio 
of alveolar macrophages to yeast cells in the fate experi­
ments about 1:3. In set 2, 0.5 ml of sterile 0.8 per cent 
NaCl was added instead of the alveolar macrophages sus­
pension. In set 3, 0.5 ml of the alveolar macrophages sus­
pension was added, followed by 0.5 ml of 0.5 per cent sodium 
deoxycholate (DOC) to disrupt the alveolar macrophages.
Tubes from sets 1, 2, and 3 were incubated at 37° C 
on a rotor (Scientific Industries, Inc.) at 30 rpm. At 0, 2 
and 4 hour intervals, 0.5 ml of 0.5 per cent DOC was added 
to sets 1 and 2 and viable plate counts, using Sabouraud 
Dextrose Agar (Difco) medium, were made from all three sets 
to enumerate the number of viable cells of C. neoformans.
The same procedures of phagocytosis and fate were 
employed for studies on human alveolar macrophages except 
that larger volumes of Eagle's BSS were used to lavage the 
human lungs. The human lungs which provided alveolar macro­
phages were obtained from a patient who died from a cerebral 
vascular accident. The human alveolar macrophages were no 
more than 5 hours old when used.
On several occasions, to obviate the possibility of 
poor alveolar macrophages viability and function, E. coli
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(ATCC 11775) was utilized in fate experiements. The condi­
tions employed were the same except that the number of E. 
coli utilized was 1 x lO^/ml in 40 per cent guinea pig 
serum and normal saline (0.85 per cent NaCl).
Electron Microscopy 
In an attempt to visualize the guinea pig alveolar 
macrophages, electron microscopy was employed. Freshly iso­
lated guinea pig alveolar macrophages were centrifuged at 
1200 X  g to form a pellet. The pellet was fixed in 4 per 
cent cacodylate buffered glutaraldehyde for 35 minutes, after 
mixing well. The alveolar macrophages were recentrifuged and 
resuspended in physiological sucrose buffer for 2 0  minutes. 
After recentrifugation for pellet formation, each sample was 
post-fixed in an osmium fixative for 2 0  minutes, then washed 
and resuspended in veronal buffer. Next, each sample was 
dehydrated in graded alcohols: 2 changes of 70 per cent for
10 minutes each, 2 changes of 95 per cent for 15 minutes, and 
2 changes of 100 per cent ethyl alcohol for 20 minutes. Each 
sample was then resuspended in propylene oxide, 2 changes for 
10 minutes each. Next, the samples were placed in a 50:50 
mixture of propylene oxide and Epon 812 for 1.0 hour. After 
this, the samples were removed from the 50:50 mixture and 
allowed to remain in pure Epon 812 for 1.0 hour. Next, the 
samples were divided into two parts and put into gelatin 
capsules. One group was embedded in Epon 812 and the other
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group was back-up embedded in Araldite. The samples were al­
lowed to polymerize at 60° C overnight before sectioning. 
Sectioning was performed on a Sorvall Porter-Blum ultra­
microtome, Model MT-1. Glass knives were used which had been 
broken on an LKB Knife Breaker. Thin sections were placed 
on #300 mesh copper grids and stained with saturated uranyl 
acetate and lead citrate. Sections were examined and photo­
graphed on an RCA EMU-3F electron microscope. Voltage em­
ployed during observation was 1 0 0 , 0 0 0  kv.
In Vivo Fate with Labeled Organisms 
In attempts to determine the fate of Ç. neoformans 
deposited in guinea pig lungs, several experiments were per­
formed.
Aerosolization 
First attempts to deposit yeast cells in guinea pig 
lungs employed a Tri-R Infection Apparatus (Tri-R Instru­
ments, Inc.). This is a self-contained nebulizing unit 
which produces a cloud containing particles to be inhaled. 
After controlled nebulization, the particles enter an en­
closed, stainless steel tank containing the animals to be 
infected, which inhale the organisms in a simulated, natural 
fashion. The infectious cloud can be exhausted through 
bacteriological filters and the animals' exterior surface 
can be sterilized by strong ultra-violet radiation. The 
time intervals and the numbers of particles entering the
28
chamber can be regulated externally by air flow control 
mechanisms. Two or three guinea pigs (approximately 700 gm 
each) were placed in the Tri-R apparatus for each experiment. 
On some occasions, before aerosolization, each animal re­
ceived 0.5 ml of 1:1000 adrenalin, intraperitoneally, in an 
attempt to retard excessive bronchial secretions. Previ­
ously H 2 ^^P0 4 -labeled organisms grown in the aforementioned 
special broth were used as a source of infectious particles 
to be placed in the nebulizer. Nebulization was carried out 
for a total of approximately 40-50 minutes (time depended 
upon formation of an adequate cloud and this depended upon 
humidity inside and outside the chamber, since the apparatus 
used filtered, atmospheric air.) Cloud decay and decontami­
nation generally lasted for 40 minutes. Total fluid aero­
solized ranged from 27-29 ml of specific Czapek broth con­
taining approximately 9.0 x 10^ yeast cells/ml. The mean 
diameter of the organisms was 5.37 y (±1.39, S. D.).
Transtracheal Instillation. In this procedure C. 
neoformans cells, grown in Czapek broth with peptone and 
yeast extract (P/YE broth), were introduced aseptically into 
the lungs. The technique involved exposing the trachea 
surgically and injecting viable yeast cells into the lungs 
via the trachea. Best results were achieved when the organ­
isms were introduced in a concentrated form (1.5-1.7 x 10? 
cells) during inspiration.
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After both the instillation and the aerosolization 
procedures, the animals were sacrificed at various time 
periods up to 6 hours by clamping the trachea. The removal 
of lungs was accomplished by a technique similar to that 
described for collection of the alveolar macrophages, ex­
cept that the animals removed from the Tri-R apparatus were 
washed in a hot soap solution to remove radioactive parti­
cles. Each set of lungs was dissected free of the trachea 
and main stem bronchi. Next, the lungs were homogenized in 
a glass homogenizer containing 15 ml of cold P/YE broth or 
cold Eagle's BSS. Samples of the homogenate were dilution 
plated onto Sabourauds dextrose agar. Three days later, 
the plates were examined for C. neoformans colonies which 
were enumerated. The remaining homogenate was counted on a 
Nuclear-Chicago liquid scintillation counter (Des Plaines, 
Illinois). A total of 3 guinea pigs was tested for each 
time period during the transtracheal instillation experi­
ments.
Activated Alveolar Macrophages and In Vitro Fate
Activated macrophages apparently have a large comple­
ment of lysosomal enzymes and, therefore, may be able to kill 
ingested organisms with greater efficiency (Axline, 1968). In 
an attempt to activate guinea pig alveolar macrophages, 6 ani­
mals were treated as follows; 3 guinea pigs were inoculated 
intravenously (IV) with 3.0 x 1Q6 heat killed Serratia mar­
cescens and 3 were inoculated with 3.0 x 10^ heat killed
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Salmonella typhosa. Ten days later, the animals were sacri­
ficed and their lungs were excised to provide a source of 
activated macrophages. Previously described fate studies 
were carried out with alveolar macrophages from each animal 
to determine their ability to kill C. neoformans. Acid phos­
phatase and beta-glucuronidase levels were also determined 
and compared with those of normal alveolar macrophages.
These enzymes are usually elevated in activated macrophages 
(Axline, 1968).
Lysosomal Enzyme Extraction 
Polymorphonuclear leucocytes (PMN's) from 500 ml of 
fresh human blood were collected on a leucopac (essentially, 
a chromatograph column packed with glass wool) at 37° C. Red 
blood cells and lymphocytes were washed from the leucopac 
with Eagle's Minimal Essential salts medium (Hyland Labs, La 
Jolla, California). At this point, the leucopac was either 
frozen until needed or used immediately. PMN's were removed 
from the column by washing it with 200 ml of 0.25 M sucrose 
to which 4000 units of sodium heparin (Organon, West Orange, 
New Jersey) had been added. The PMN suspension was concen­
trated by centrifugation at 27,000 x g for 10 minutes. The 
pellet of PMN's was resuspended in 7.0 ml of the sucrose and 
heparin solution. Next, the pellet suspension was mixed for 
5 minutes on a LaPine mixer in a test tube with a Tri-R 
teflon tissue homogenizer. The resulting cell homogenate was 
centrifuged for 1 0  minutes at 600 x g to remove nuclei, cell
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wall fragments, and glass wool. The supernatant fluid con­
taining the granules was decanted off and held at 4° C for 
the next step. The pellet was suspended again in sucrose- 
heparin and centrifuged under the same conditions. The two 
supernatant fluids were then combined and centrifuged at
27,000 X g for 20 minutes. The supernatant fluid was dis­
carded and the pellet of PMN granules was resuspended in
0.25 M sucrose (without heparin) and lysed by freeze thaw­
ing 6 times. This material contained the myeloperoxidase 
preparations used throughout the research.
Enzyme Activity 
Peroxidase acts upon hydrogen peroxide as follows:
peroxidase + H 2 O 2------ > compound
compound + AH 2 (donor)------ > peroxidase + H 2O + A
The rate of decomposition of H 2 O 2 by peroxidase with 
o-dianisidine as a hydrogen donor is determined by measuring 
the rate of color development at 460 na.
The stock substrate was prepared as follows: 1.0 ml
of 30 per cent H 2O 2 (Merck*s Superoxol) was diluted to 100 ml 
with distilled H 2O. Working substrate was prepared by dilu­
ting 1.0 ml of stock H 2O 2 to 100 ml with 0.01 M phosphate 
buffer, pH 6.0 (prepared fresh daily). The dye, 1 per cent 
o-dianisidine in methyl alcohol, was also prepared fresh 
daily. Procedure: 0.05 ml of dye was added to 6.0 ml of
working substrate. From this solution, 2.9 ml was trans-
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ferred to a glass cuvette and the remainder to a control 
cuvette. At zero time, 0.1 ml of PMN homogenate was added 
to the first cuvette. The contents of the cuvette were 
mixed by inverting and the absorbancy was recorded every 15 
seconds (B & L Spectronic 20) for 2.0 minutes to determine 
the rate of change per minute. One unit of peroxidase 
activity is that amount of enzyme decomposing 1 . 0  ym of 
peroxide per minute at 25° C.
Protein was measured by the Biuret (Gornall, 
Bardawill, and David, 1949) method and the activity of each 
enzyme preparation was calculated and adjusted to a standard 
activity of 150 units/0.1 ml of PMN homogenate.
Alveolar macrophages harvested from guinea pig lungs 
and human lungs were tested for the presence of myeloperoxi­
dase. The methods for enzyme extraction and assay were the 
same and the macrophages were collected as previously des­
cribed.
Assay of Fungicidal Activity 
One hundred and fifty units of the myeloperoxidase 
preparation was added to 2.0 ml of sterile 0.1 M phosphate 
buffer, pH 5.0, in a siliconized test tube (100 x 15 mm). 
Appropriate amounts of Nal, NaCl, and living organisms were 
added. Finally, in order to initiate the reaction, various 
amounts of H 2 O 2 in phosphate buffer were added. Tubes were 
incubated at room temperature. At 0, 15, 30, 60 and 90
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minutes, 1 . 0  ml was removed from the reaction mixture and 
diluted in 9.0 ml of sterile distilled H 2 O. The serial dilu­
tions were plated on either Sabouraud Dextrose Agar or Brain 
Heart Infusion Aga and incubated at room temperature until 
colonies could be visualized with 6 x magnification.
In certain experiments, inhibitors of the myeloper­
oxidase reaction were employed. The following inhibitors 
were used in varying amounts: 3 amino-triazole and potas­
sium cyanide.
Acid Phosphatase. Lysosomal granules which provided 
the myeloperoxidase preparations were also tested for acid 
phosphatase and beta-glucuronidase activity. Enzyme activity 
was determined according to the methods described in the 
Worthington Biochemical Enzyme Manual (Worthington, Freehold, 
New Jersey). Acid phosphatase acts on o-carboxy phenyl phos­
phate. The rate of hydrolysis of o-carboxy phenyl phosphate 
is determined by following the increase in absorbancy at 
300 mu due to liberation of salicylic acid. One unit is 
equivalent to one micromole of o-carboxy phenyl phosphate 
hydrolyxed per minute, at pH 5.0 and 25° C.
Beta-glucuronidase. Detection of beta-glucuronidase 
was also determined by the methods described in the Worthing­
ton Biochemical Enzyme Manual. The enzyme acts on phenol- 
phthalein glucuronidate at the optimum pH of 4.5. One unit 
of beta-glucuronidase activity is that amount which cleaves 
one micromole of phenolphthalein glucronide per minute at
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37° C.
In both enzyme assays, controls consisted of all re­
action components except the myeloperoxidase preparation, 
which was substituted with distilled H 2 O.
CHAPTER III 
RESULTS
In Vitro Phagocytosis Studies 
Results of initial phagocytosis experiments indi­
cated that guinea pig alveolar macrophages could phagocytize 
nonencapsulated C. neoformans, strain CIA, within 15 minutes. 
Based on this observation, it was decided to study the bi­
ological conditions necessary to achieve maximum phagocytosis 
in vitro. Serum promotes engulfment in many vitro and in 
vivo situations. Therefore, it was decided to learn what 
concentration of serum (if any) would provide the maximum 
phagocytosis of C. neoformans. The effect of various serum 
concentrations in an ^  vitro environment are shown in Figure
1. Although the experiments were allowed to proceed for 120 
minutes, maximal phagocytosis was achieved in 60 minutes.
The control, which was the system without serum, showed only 
an 18 per cent phagocytosis; the system containing 65 per 
cent autologous serum showed approximately 48 per cent phago­
cytosis. The system that employed 45 per cent gave 52 per 
cent phagocytosis, whereas the 30 per cent serum system gave 





















3 0 %  
4 5  % 
6 5  %
1 206 0 9 03 0
T I M E / M I N U T E S
Figure 1--Optimal Phagocytosis Experiment: Effect
of serum concentration on phagocytosis by alveolar macro­
phages .
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alveolar macrophage ratio in these experiments was approxi­
mately 3:1.
Once the optimal serum concentration was determined, 
the next step was to vary the yeast cell alveolar macro­
phages ratio. Figure 2 demonstrates that all the yeast cell 
to alveolar macrophages ratios, except the 1 :1 , yielded good 
percentage phagocytosis. However, when one examines the 
phagocytic index, it is evident that the 2:1 and 4:1 ratios 
had better indicies and thus provided the optimal conditions 
for phagocytosis.
Effect of Capsule Polysaccharide 
on Phagocytosis
Since cryptococcal polysaccharide is known to inhibit 
phagocytosis by human PMN's, an experiment was devised to 
determine if it also inhibits phagocytosis by alveolar mac­
rophages. The usual phagocytic assay was carried out using 
30 per cent autologous guinea pig serum, alveolar macrophages 
and nonencapsulated cryptococcal cells. To this system, 
varying amounts of partially purified cryptococcal capsular 
polysaccharide was added. At the end of 60 minutes, the per­
centage phagocytosis was determined. Table 1 demonstrates 
these results. It required only 100 yg of capsular material 
to reduce the percentage phagocytosis from 52 per cent (con­
trol) to 30 per cent. Adding up to 1,800 yg of capsular 
material reduced the percent phagocytosis by only 6 more 
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Figure 2— Optimal Phagocytosis Experiment: Effect
of yeast cell to alveolar macrophage ratio on percentage 
phagocytosis and phagocytic index.
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TABLE 1
GUINEA PIG ALVEOLAR MACROPHAGES: INHIBITION
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In Vitro Fate Studies 
An important objective of the research was to de­
termine if guinea pig alveolar macrophages could kill the 
phagocytized cryptococcal cells. Figure 3 is a graphic 
representation of the results. The results indicate that 
33.9 per cent of the cryptococcal cells remained viable in 
the system with alveolar macrophages (AV/W) at the end of 4 
hours, and that 31.3 per cent of the cryptococcal cells re­
mained viable in the system without alveolar macrophages 
(AV/WO). Trypan blue uptake by the guinea pig alveolar mac­
rophages at the end of the 4 hours incubation showed that 
84 per cent of the phagocytic cells remained viable.
To obviate the possibility that the alveolar macro­
phages were functionally inadequate, Escherichia coli was 
tested in the phagocytic system. Figure 4 demonstrates that 
under the same conditions, only 4 . 6 per cent of the E . coli 
remained viable after 2 . 0  hours incubation with the guinea 
pig alveolar macrophages.
Activated Alveolar Macrophages 
It has been shown that macrophages may be activated 
by endotoxin and by gram negative bacteria. Activated macro­
phages contain greater quantities of lysosomal enzymes and, 
in certain instances, have been shown to have increased 
bactericidal capacity. Heat killed Salmonella typhosa and 
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Figure 3— Alveolar Macrophage Fate Experiment: Non­
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Figure 4— Alveolar Macrophage Fate Experiment: E.
coli incubated with (AV/W) or without (AV/WO) guinea pig 
alveolar macrophages.
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in an attempt to activate their alveolar macrophages. Table 
2 shows the results of these studies. It is apparent that 
both organisms caused an increase in enzyme activity (acid 
phosphatase and beta-glucuronidase) per mg of protein. Acid 
phosphatase went from an average of 96.0 to 128.7 (activity/ 
mg protein) and beta-glucuronidase went from 27.3 to 33.6 
(activity/mg protein).
Activated alveolar macrophages from these animals 
were tested for their ability to kill non-encapsulated 
cryptococcal cells. Figures 5 and 6 show the results of fate 
experiments using S. typhosa and S. marcescens activated 
macrophages, respectively. Note that after 4.0 hours incu­
bation, no difference in killing was observed in the presence 
or absence of activated alveolar macrophages.
Phagocytosis by Human Alveolar Macrophages
One of the long range goals of this research was to 
determine if human alveolar macrophages play a role in the 
pathogenesis of cryptococcosis. An opportunity arose to pos­
sibly answer this question when a piece of human lung became 
available from a patient who died from a cerebral vascular 
accident.
The right lower lobe of the lung was lavaged with 
Eagle's BSS and the alveolar macrophages were harvested.
The alveolar macrophages were used in a standard phagocytic 
system in an attempt to see if they could phagocytize non-
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TABLE 2
ACID PHOSPHATASE AND BETA-GLUCURONIDASE ACTIVITY 



















Phosphatase 96.0 128.7 119.3
Beta-
glucuronidase 27.3 33.6 37.2
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Figure 5— Activated Macrophage Fate Experiment: 
Non-encapsulated C. neoformans incubated with (AV/W) or 
without (AV/WO) guinea pig alveolar macrophages activated 
with heat killed Salmonella typhosa.
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Figure 6 — Activated Macrophage Fate Experiment; 
Non-encapsulated C. neoformans incubated with (AV/W) or 
without (AV/WO) guinea pig alveolar macrophages activated 
with heat killed Serratia marcescens.
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encapsulated cryptococcal cells. After 60 minutes incubation 
at 37° C, samples of the cells were observed for percentage 
phagocytosis. Essentially no phagocytosis (2.0 per cent) was 
observed. Examination of the alveolar macrophages by trypan 
blue indicated that less than 40 per cent of the cells were 
viable. Light microscopic observation revealed a lack of 
cellular detail and poor morphology.
Electron Microscopy of Alveolar Macrophages 
Alveolar macrophages from the first lung washings 
were discarded because they were presumed to be compromised 
metabolically. Electron microscopic observation of alveolar 
macrophages which were obtained from the first lavage indi­
cated that the cells were, indeed, unhealthy. Generally, 
they lacked intact mitochondria, had disorganized endoplas­
mic reticulum, lacked good nuclear structure, and lysosomal 
particles (Figure 7). On the other hand, alveolar macro­
phages obtained from the second and third lavages had the ap­
pearance of macrophages that were alive and healthy (Figure 
8 ). Ultrastructural examination of the non-encapsulated 
cryptococcal cells demonstrated that a small amount of 
capsule material remained on the cells (Figure 9). Also, it 
should be noted that the cryptococcal cells were probably 
alive because of the presence of a white ring between the 
cell wall and the capsular material as suggested by Edwards, 
Gordon, Lapa, and Ghoirse (1967).
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Figure 8 — Guinea pig alveolar macrophages from 





Figure 9— Budding non-encapsulated cryptococcal cell. 
22,100x. Note white ring (R) around mother cell. These 
yeast cells were incubated with guinea pig alveolar macro­
phages for 2.0 hour vitro. Note cell wall (CW), capsule




Attempts were made to examine alveolar macrophages 
that had phagocytized cryptococcal cells vitro. It was 
hoped that yeast cells would be seen inside phagosomes and 
that, perhaps, there would be evidence of lysosomes emptying 
their contents into the phagosome. Figure 10 shows a crypto­
coccal cell inside a guinea pig alveolar macrophages after 
4 hours incubation in a typical phagocytosis experiment. The 
cell is budding and appears to be inside a vacuole. The EM 
grid blocked the view of other cellular components. However, 
even though the stain made the photograph foggy, no lyso­
somes appeared close to the organism. Moreover, because of 
the presence of the white line around the mother yeast cell, 
it appeared to be viable.
In Vivo Fate Studies 
Since the vitro fate studies demonstrated that 
guinea pig alveolar macrophages did not kill engulfed crypto­
coccal cells, experiments were devised to study vivo fate. 
Before the vivo fate experiments could be accomplished, it 
was necessary to devise a medium that allowed growth of 
cryptococcal cell with no capsule and in which the yeast 
cells were less than 5.0 y in diameter (ordinarily growth in 
liquid media produces large cells and large capsules). Di­
ameters of less than 5.0 y would allow passage of cells into 
the alveolar space.
Table 3 shows the results of culturing C. neoformans 
in various modifications of basic Czapek medium. The basic
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Figure 10— Budding cryptococcal cell phagocytized 
by a guinea pig alveolar macrophage. Note white ring (R), 




MODIFIED CZAPEK MEDIUM: 
EXPERIMENTAL 
MODIFICATIONS
Modifications gm/ 1 0 0  ml
Growth
Characteristics
1. NaNOg 2 . 0 7-8% diameter
Glucose 1 . 0 Capsule varies
K 2 HPO4 0 . 1 Growth good
2. NaNO] 2 . 0 5-6% diameter
Glucose 0 . 1 Small capsule
K 2 HPO4 0 . 1 Growth poor
3. NaNO] 2 . 0 8- 1 0 % diameter
Glucose 0 . 1 Large capsule 
Growth good
4. NaNOg 3.0 9-10% diameter
Glucose 0 . 1 Large capsule 
Growth good
5. NaNO] 3.0 4.5-5.5% 
diameter
Glucose 0 . 1 Small capsule
K 2 HPO4 0 . 1 Growth poor
Modified Czapek medium contains; MgSO*, 0.5 gm/1; 
KCl, 0.5 gm/1; FeSO^, 0.01 gm/1; Peptone, 5.0 gm/1; and 
yeast extract 1 . 0  gm/1 .
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Czapek mediumf plus 3.0 gm/per cent NaNOg, 0.1 gm/per cent 
D-glucose, and 0.1 gm/per cent K 2 HPO4 , yielded small cells 
and small capsules, but poor growth. In other words, a 
small, lightly encapsulated cell could be produced, but its 
growth was poor.
Based on the observation that the K2 HPO4 somehow de­
creased the size of the cells, a large series of modifica­
tions of Czapek medium were tested for their ability to 
produce small, preferably non-encapsulated cells, but with 
adequate growth. Table 4 contains the results of experi­
ments in which varying concentrations of K 2HPO4 were em­
ployed with an increased glucose concentration ( 2 0 0  mg/ 1 0 0  
ml) in the basic Czapek medium. The medium containing 25 mg 
K 2 HPO4 /IOO ml, produced the most desirable cellular charac­
teristics after 3 days of growth, i. e., adequate growth and 
no capsules, but the cells were too large. Table 5 shows the 
results obtained with the next set of modifications in which 
basic Czapek medium was prepared ^  novo, either without 
yeast extract, with yeast extract ( 1 0 0  mg/ml) and peptone 
(10 mg/100 ml), or with yeast extract (100 mg/ml). The 
K 2 HPO4 concentration of 50 mg/100 ml in the presence of pep­
tone and yeast extract gave the best results, with only 1 0  
per cent encapsulated cells, a cell diameter of 4.5 y, and 
very good growth.
Even though the foregoing medium yielded good growth 
and cell size, an even smaller cell size was desirable.
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TABLE 4
GROWTH CHARACTERISTICS AND DIAMETER OF 
C. NEOFORMANS GROWN IN DIFFERENT 
VARIATIONS OF CZAPEK MEDIUM*
K 2 HPO4 mg/ 1 0 0  ml Growth Characteristics
0 4.25 X 10^ cells/ml 
6 . 0 m  diameter 
10% Encapsulated
25 6.3 X 10^ cells/ml 
5 . Om diameter 
Non-encapsu1 ated
50 7.15 X  10® cells/ml 
5.5y diameter 
70% Encapsulated
1 0 0 7.85 X  10® cells/ml 
5.5m diameter 
70% Encapsulated
150 8.9 X  10® cells/ml 
6 .Om diameter 
100% Encapsulated
♦containing glucose, 2 0 0  mg/ 1 0 0  ml.
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TABLE 5
GROWTH CHARACTERISTICS AND DIAMETER OF 
Ç. NEOFORMANS GROWN IN DIFFERENT 
VARIATIONS OF CZAPEK MEDIUM
K 2 HP0 4  










8 . 1  X 1 0 6  cells/ml 
6 .0|j diameter 
Non-encapsulated
11.0 X  10® cells/ml 




8.7 X 1 0 6  cells/ml 
6 . Op diameter 
20% Encapsulated
11.0 X  1 0 6  cells/ml 




10.1 X  1 0 6  cells/ml 
6 .Op diameter 
20% Encapsulated
1 0 . 2  X  1 0 ®  cells/ml 




11.3 X  1 0 6  cells/ml 
5. 5p diameter 
Non-encapsulated
10.5 X  1 0 6  cells/ml 
6 . Op diameter 
20% Encapsulated
1 0 0 No
growth
13.1 X  1 0 6  cells/ml 
5.25p diameter 
Non-encapsulated
8 . 2  X  1 0 ®  cells/ml 




14.0 X  1 0 6  cells/ml 
6 .Op diameter 
Non-encapsulated





14.0 X  1 0 6  cells/ml 
6 .Op diameter 
Non-encapsulated
10.0 X  1 0 6  cells/ml 
6 . Ovi diameter 
30% Encapsulated
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Table 6 shows the results obtained with another set of media 
variations. The media varied not only in K 2 HPO4 concentra­
tion, but also with respect to presence or absence of glu­
cose. Examination of the cells revealed that the medium 
containing 50 mg/100 ml and Peptone without glucose 
yielded fair growth, no capsules, and desirable cell size 
(4.0 y, range 3.6-4.7 y).
Aerosolization of Radioactive 
Cryptococcal Cells
Several attempts were made to aerosolize the crypto­
coccal cells using the Tri-R infection apparatus and guinea 
pigs. Viable plate counts from the homogenized guinea pig 
lungs that received the radioactive cells showed only 150 
organisms (av.) per lung at "0" time. No cryptococcal cells 
could be cultured from the lung 4.0 hours after aerosoliza­
tion. Radioactivity decreased from 555 cpm at zero time to 
435 cpm after 4 hours exposure. By dilution plate count of 
the nebulizer solution, the guinea pigs were exposed to ap­
proximately 2.52 X 10^ organisms during the aerosolization 
time period. Obviously, only a very small percentage of the 
organisms reached the alveolar spaces. Although it appeared 
that the guinea pigs were able to clear the cryptococcal 
cells, the number of organisms inhaled was too small to draw 
any firm conclusions. Moreover, the radioactivity data were 




GROWTH CHARACTERISTICS AND DIAMETER OF 
Ç. NEOFORMANS GROWN IN DIFFERENT 
VARIATIONS OF CZAPEK MEDIUM
K 2 HP0 4  





0 1 . 0  X 105 cells/ml 
8 . 5y diameter 
100% Encapsulated
No growth
25 3.0 X 105 cells/ml 
7. Op diameter 
100% Encapsulated
2 . 0  X  1 0 ^  cells/ml 
5. Op diameter 
Non-encapsulated
50 7.0 X  105 cells/ml 
6.5p diameter 
70% Encapsulated
9.0 X 103 cells/ml 
4. Op diameter 
Non-encapsulated
75 8 . 0  X 105 cells/ml 
5. 5p diameter 
40% Encapsulated
1.0 X  105 cells/ml 
4. 5p diameter 
Non-encapsulated
1 0 0 1.4 X 1 0 6  cells/ml 
6 .Op diameter 
50% Encapsulated
1 . 2  X 1 0 6  cells/ml 
5.Op diameter 
Non-encapsulated
125 1.4 X 10® cells/ml 
5.Op diameter 
40% Encapsulated
1 . 0  X 1 0 6  cells/ml 
4.7p diameter 
Non-encapsulated
150 1 . 6  X 1 0 6  cells/ml 
5.5p diameter 
50% Encapsulated




Transtracheal Instillation Experiments 
Because of the problems encountered in the aerosoli­
zation experiments, it was decided to look for an alternate 
method to determine vivo fate of C. neoformans. Conse­
quently, it was decided that more cells could be deposited 
in the lungs if the organisms were injected directly into 
the distal part of the trachea.
This was accomplished by injecting approximately 
1.5-1.7 X 107 viable cryptococcal cells into the lower 
trachea of the guinea pigs along with 2.0 cc of air. The 
animals were sacrificed either immediately or at varying time 
intervals post instillation by clamping the trachea. As in 
previous experiments, the lungs were removed, homogenized, 
scored for radioactivity, and the number of viable C. neo­
formans was determined. Table 7 shows the results of this 
study. It will be seen that the average number of viable 
cryptococcal cells dropped from 1.51 x 10^ to 1.24 x 1 0 ^ per 
whole lung over the 360 minute time period. The 90 minute 
and 360 minute data are also presented in Figures 11 and 12.
A reduction in viability of only 18 per cent occurred after 
6 . 0  hours incubation, with a concomitant decrease in 
counts of 14 per cent. Based on these observations, it ap­
peared that the cryptococcal cells were not killed in the 
guinea pig lungs.
Fungicidal Activity of Myeloperoxidase 
It has been shown that myeloperoxidase (MPO) extracted 
from human PMN's, in conjugation with a halide and hydrogen
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TABLE 7
DEPOSITION AND CLEARANCE OF 32p LABELED 
LOW-ENCAPSULATED C. NEOFORMANS 







Cell count X 10?
32p- counts/lung 
CPM X  106
0 min 1 1.61 1.43
0 min 2 1.43 (1.51 av) 1.35 (1.37 av)
0 min 3 1.51 1.39
30 min 4 1.52 1.38
30 min 5 1.58 (1.52 av) 1.28 (1.36 av)
30 min 6 1.46 1.41
90 min 7 1.53 1.30
90 min 8 1.47 (1.50 av) 1.30 (1.27 av)
90 min 9 1.49 1.24
180 min 1 0 1.30 1.31
180 min 1 1 1.41 (1.38 av) 1.24 (1.27 av)
180 min 1 2 1.45 1.26
360 min 14 1.31 1.23













Figure 11— Deposition and clearance of ^2p labeled 


















Figure 12— Deposition and clearance of labeled 
neoformans after transtracheal instillation.
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peroxide, exhibits a bactericidal effect (Klebanoff, 1965; 
Lehrer, 1969). Except for C. albicans it is not known 
whether this MPO system can effectively kill various fungi, 
including C. neoformans.
To answer this question, a series of experiments was 
designed to test the ability of crude lysosomal extracts 
(containing MPO), a halide, and H 2 O2 to kill cryptococcal 
cells. Table 8 demonstrates dilution plate counts (obtained 
from the 1 x 10“3 dilution) when various organisms were 
tested against several combinations of the components of the 
MPO system. In these preliminary experiments, 470 units of 
MPO, 5 X 1 0 " 4  M H 2 O2 , and 1 x 10“  ^M Nal (final conc.) were 
used. Examination of Table 8 reveals that the combination 
of MPO-NaI-H202 killed encapsulated and non-encapsulated 
C. neoformans, C. albicans, and S. schenckii. It should also 
be noted that R. oryzae was not killed. Also, Nal-H202r Nal, 
or H 2 O 2 by themselves were not effective in killing. How­
ever, a decrease was observed when the Nal-H2 0 2  combination 
was used against the cryptococcal cells.
Although these results were interesting, the studies 
lacked a good control for growth and the proper concentra­
tion of the halide and H 2 O2 . Therefore, better controlled 
experiments were performed to answer conclusively whether or 
not the MPO-system could kill cryptococcal cells.
Table 9 demonstrates various conditions which were 
used to test the killing of encapsulated cryptococcal cells.
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TABLE 8
EFFECT OF MYELOPEROXIDASE (MPO) 
SYSTEMS ON VIABLE COUNTS 
OF VARIOUS FUNGI
Organism System Viable Counts/min^
0 15 30 60 90
ClA^ MPO + H 2 O 2 












+ H 2 O 2 

















Low pH3 MPO + H 2 O2 












+ H 2O 2 

















C. albicans MPO + Nal
+ H 2 O 2 0 . 0 0 . 0 0 . 0 0 . 0 0 . 0
S . schenckii MPO + Nal
+ H 2 O 2 7.0 0 . 0 0 . 0 0 . 0 0 . 0
R. oryzae MPO + Nal 
+ H 2 O 2 17.5 2 1 . 0 28.0 27.0 26.0
^Encapsulated C. neoformans
2Average count of two plates from 1 x lQ-3 dilution 
^Non-encapsulated C . neoformans
TABLE 9
EFFECT OF MYELOPEROXIDASE (MPO) AND SUPPLEMENTS ON THE
VIABILITY OF ENCAPSULATED C. NEOFORMANS (CIA)
System Halide M
MPO
H 2 O 2 M
Percentage via)ole cells/min.
Units 0 15 30 60
P0 4 ~Buffer 
pH 5.0 —-- — — — — — — 1 0 0 . 0 99.3 89.2 84.8
MPO --— 150 --- 87.0 99.3 85.6 87.8
H 2 O 2 —— — —-- 5.0x10-5 N. D.* 94.5 N. D.* 91.7
Nal 1x10-4 --— --- 83.5 88.5 84.1 76.2
H 2 O 2 + Nal 5x10-5 --- 5.0x10-5 82.2 75.3 N. D.* 83.5
MPO + Nal 8.3x10-4 150 —-- 104.0 1 1 1 . 0 76.6 93.3
MPO + Nal 
+ H 2 O 2 1x10-4 150 5.0x10-5 0 0 0 0
NaCl + H 2 O 2 2x10-3 — — — 3x10-3 84.1 78.1 84.8 0
NaCl + MPO 2x10-3 150 — —— 105.3 89.9 116.6 106.8
NaCl 2x10-3 —-- —-- 82.1 1 0 0 . 0 84.5 86.9
MPO + NaCl 




Tested separately, MPO, ^2^2 Nal, in the quantities used 
were not effective in killing encapsulated cells of C. neo­
formans (CIA). There was essentially no change in viability 
over a 60 minute time period when compared with the PO^-buf- 
fer control. The combinations of Nal-H2 0 2  and MPO-Nal were 
also ineffective, since the percentage viability remained at 
83.5 and 93.3, respectively, after 60 minutes. However, 
when the combination of MP0 -NaI-H2 0 2  was incubated with the 
cryptococcal cells, there was immediate killing. It should 
be noted that death was recorded at zero time. Actually, 
zero time was approximately 5 .0 minutes after all the com­
ponents were mixed together. It required 5.0 minutes to 
dilution plate the reaction mixture and apparently this was 
enough time to allow for 1 0 0  per cent killing.
An attempt was made to substitute NaCl for the Nal. 
The combination of NaCl-H2 0 2  showed complete killing in 60 
minutes (Table 9). The combination of MPO-NaCl-H2 0 2  showed 
approximately 67 per cent killing after 60 minutes. This 
seemed to indicate that Cl” could be substituted for I” . 
However, the final concentration of H 2 O 2 was higher than in 
previous experiments (Table 8 ) and this may have accounted 
for the killing observed when NaCl and H 2 O 2 were used alone. 
This observation also negates the possibility that MPO-NaCl- 
H 2 O 2 is capable of killing C. neoformans because it must be 
assumed the H 2 O 2 (3 x 10”3 M) was actually responsible for 
the death of the cells.
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Table 10 demonstrates the results of a series of 
experiments similar to those seen in Table 9. The major 
difference was in the use of non-encapsulated cells. As be­
fore, MPO, H 2 O 2 , and Nal when used separately did not kill 
the organisms when compared to the buffer system. The com­
binations of Nal-H2 0 2 , MPO-H2 O 2 , and MPO-Nal, resulted in 
81.3 per cent, 97.0 per cent and 81.8 per cent viability, 
respectively, after 60 minutes. The combination of MPO-Nal- 
H 2 O 2 killed all the cells at zero time.
Because the concentration of H 2 O 2 used in the experi­
ments involving the NaCl (Table 9) was too high, the concen­
tration was lowered when it was used with the non-encapsula­
ted organisms. The results showed that no killing occurred 
after 60 minutes when MPO-NaI-H2 0 2  was incubated with the 
cryptococcal cells.
Klebanoff (1968) showed that myeloperoxidase could 
be separated from other bactericidal agents extracted from 
PMN's. This conclusion was based on the heat lability (100° 
C/10 minutes) and the inactivation by cyanide and azide. To 
test the possibility that MPO was not the agent which con­
tributed to the death of cryptococcal cells, another series 
of experiments was devised. The results are shown in Table 
11. The major point to be noted is that when MP0 -NaI-H2 0 2  
was incubated with KCN (3 x 10"3M) or 3-amino triazole (3AT) 
( 1 X 1 0 “2m) and encapsulated cells, no killing was observed. 
When MP0-NaI-H202 was incubated without either inhibitor.
TABLE 10
EFFECT OF MYELOPEROXIDASE (MPO) AND SUPPLEMENTS ON THE
VIABILITY OF NON-ENCAPSULATED C. NEOFORMANS (CIA)
System Halide M
MPO Percentage via ble cells/min.
Units 0 15 30 60
P0 4 ~Buffer 
pH 5.0 — —— --— ———' 1 0 0 . 0 107.7 65.3 105.3
MPO — —— 150 ——— 104.5 114.7 1 0 0 . 0 90.9
H 2 O 2 — — — — — — 0.5x10-4 8 8 . 0 85.3 108.0 90.6
Nal 1x10-4 — — — — — — 78.0 104.0 93.3 106.6
H 2 O 2 + Nal 1x10-4 --- 0.5x10-4 1 0 0 . 0 1 0 0 . 0 1 2 0 . 0 81.3
MPO + H 2 O 2 — — — 150 0.5x10-4 98.0 108.7 93.2 97.0
MPO + Nal 1x10-4 150 — — — 119.3 N. D.* 84.0 81.8
MPO + Nal 
+ H 2 O 2 1x10-4 150 0.5x10-4 0 0 0 0
MPO + NaCl 





EFFECT OF VARIOUS INHIBITORS ON THE MYELOPEROXIDASE (MPO)
SYSTEM USING ENCAPSULATED C. NEOFORMANS (CIA)









P0 4 “Buffer 
pH 5.0 --- —-- --- — — — 1 0 0 . 0 1 0 0 . 0
MPO --- --- --- 44 1 0 0 . 0 157.0
MPO --- — — — 44 — — — 1 0 0 . 0 1 0 1 . 0
MPO + Nal + 
H 2 O 2 --- — —— --- 44 0 . 0 0 . 0
MPO + Nal + 
H 2 O 2 --- --— 44 — —— 1 0 0 . 0 114.0
Nal + H 2 O 2 + 
KCN 3x10-3 --— — —— --- 1 0 0 . 0 77.9
MPO + Nal + 
H 2 O 2 + KCN 3x10-3 — — — --- 44 1 0 0 . 0 92.1
MPO + Nal + 
H 2 O 2 + 3AT 1x10-2 — — — 44 1 0 0 . 0 105.1
Nal + H2O2 + 





killing occurred immediately. If the MPO was heated to 100°
C for 10 minutes, this also effectively inhibited killing by 
the MPO-system. Also, in this set of experiments, the con­
centration of MPO was decreased to 44 units without effecting 
its activity. The combination of NaI-H2 0 2 -3AT and Nal-H2 0 2 “ 
KCN had no effect on the viability of the cryptococcal cells.
Table 12 demonstrates results similar to those shown 
in Table 11. The major difference was that non-encapsulated 
cryptococcal cells were used instead of encapsulated cells. 
Again, KCN, 3AT, and heated MPO inhibited the killing power 
of the MPO-halide-H2 0 2  system. As before, only 44 units of 
MPO were employed in the MPO-system.
Assay of Myeloperoxidase from 
Various Leucocyte Extracts
Since the MPO-system efficiently killed cryptococcal 
cells, it was decided to look for the enzyme in alveolar mac­
rophages. Guinea pig and human alveolar macrophages were 
disrupted and treated in a manner similar to that used with 
the human peripheral leucocytes from leucopacs. After dis­
ruption, extracts were assayed for the presence of MPO.
Figure 13 shows the results of these assays. It is noted 
that extracts from human peripheral leucocytes extracts num­
ber 6 and 7 (0.1 ml) caused an increase in optical density 
when incubated with H 2 O 2 and 1 per cent o-dianisidine. Us­
ing the same substrate, purified horse-radish peroxidase 
(Worthington, Biochemical, Freehold, New Jersey) also caused
TABLE 12
EFFECT OF VARIOUS INHIBITORS ON THE MYELOPEROXIDASE (MPO)
SYSTEM USING NON-ENCAPSULATED C. NEOFORMANS (CIA)










pH 5.0 ——— --- —-- — — — 1 0 0 . 0 1 0 0 . 0
MPO —-- 44 --- 1 0 0 . 0 97.3
MPO --- --- --- 44 1 0 0 . 0 96.2
MPO + Nal +
H 2 O 2 --- --- —-- 44 0 0 . 0 0 0 . 0
MPO + Nal +
H 2 O 2 --- 44 — ——
Nal + H 2 O 2 t 
KCN 3x10-3 --- --- — — — 1 0 0 . 0 120.5
MPO + Nal + 
H 2 O 2 -- --- — — — 44 0 0 . 0 0 0 . 0
MPO - Nal - 
H 2 O 2 - KCN 3x10-3 — — — 44 1 0 0 . 0 87.9
Nd.1 — H 2 O 2 “ 
3AT --- 1 x 1 0 - 2 —-- 1 0 0 . 0 96.7
MPO - Nal - 





—  Extract No. 6 
1 . 0  ——  Extract No. 7
EB Horseradish peroxidase 
, *  Human Alveolar macrophages 














T IM E /S E C O N D S
Figure 13— Assay for myeloperoxidase extracted from 
various sources. Increase in absorbance versus time in 
seconds.
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an increase in 0. D. When extracts from guinea pig and 
human alveolar macrophages were tested with the same sub­
strates very little increase in optical density was observed 
with guinea pig alveolar macrophages. The human alveolar 
macrophages preparation showed an increase, but the prepara­
tion contained 11 per cent PMN's and an undetermined number 
of red blood cells. Converting increase in 0. D. versus 
time to o-dianisidine units, extracts 6 and 7 contained 748 
and 4900 units/ml, respectively. Guinea pig alveolar macro­
phages contained 1 1 0  units/ml and human alveolar macrophages 
contained 132 units/ml. The purified horse-radish peroxidase 
contained 2 0 2 0  units/ml.
CHAPTER IV 
DISCUSSION
It was not surprising to find that guinea pig alveo­
lar macrophages can phagocytize non-encapsulated cryptococcal 
cells. It has already been shown that human PMN's are cap­
able of phagocytizing cryptococci (Bulmer and Sans, 1967). 
Since alveolar macrophages are the phagocytes of the lung, 
one would expect to observe good phagocytosis of particles 
entering the lung. However, it appears that phagocytosis by 
alveolar macrophages ^  vitro is somewhat lower than that 
seen with PMN's (Bulmer and Sans, 1967). Maximal phagocy­
tosis ranged between 57-60 per cent for alveolar macrophages, 
while human PMN's averaged about 72 per cent. However, com­
parison of the two cell lines may not be valid for obvious 
reasons. It was interesting to note that optimal phagocytosis 
was influenced by serum concentration and yeast cell to alveo­
lar macrophage ratio (Figures 1 and 2). Human PMN's can 
phagocytize with surprising efficiency in the apparent ab­
sence of seru.Ti (Tacker, et , 1972).
Capsular polysaccharide from C. neoformans impairs 
phagocytosis by guinea pig alveolar macrophages (Table 1).
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It appears that as little as 100 ]ig/ml can effectively re­
duce phagocytosis ^  vitro to almost one-half of the normal 
value. Higher levels of polysaccharide (up to 1800 pg/ml) 
were only slightly more effective than the 1 0 0  yg level.
This was not an unpredictable finding since Bulmer and Sans 
(1968) showed the same thing using human PMN's. It is 
important, however, because it had been reported previously 
that non-encapsulated C. neoformans can produce significant 
amounts of capsular material in human lung tissue after 4.0 
hours incubation (Farhi, 1969).
Intracellular fate studies demonstrated that guinea 
pig alveolar macrophages cannot kill phagocytized crypto­
coccal cells within 4.0 hours ijn. vitro (Figure 3) . There was 
a decrease in viability, both with and without alveolar mac­
rophages, but this was apparently due to an anticryptococcal 
serum factor (Tacker, et ^ . , 1972) . This is in contrast to 
the finding that human PMN's are effective in killing C. 
neoformans (Tacker, et ^ . , 1972; Diamond, Root, Bennett,
1972). Human blood monocytes have been shown to be rela­
tively ineffective in killing C. neoformans (Diamond, et al., 
1972), however blood monocytes are metabolically different 
from alveolar macrophages (Karnovsky, 1962; Oren, Farham, 
Saito, Milofsky and Karnovsky, 1963). It is possible that 
the alveolar macrophages were metabolically compromised owing 
to the experimental procedures used, thus leaving them in­
capable of killing ingested organisms. This possibility was
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ruled out, however, by showing that they could effectively 
kill E. coli within 2.0 hours (Figure 4) and that 84 per cent 
of them appeared to be viable by the trypan blue exclusion 
test. This finding is in contrast to that reported by 
Pavillard (1963), who reported that rat alveolar macrophages 
were ineffective in killing intracellular E. coli strain BV. 
However, Pavillard used tissue culture alveolar macrophages 
and a different strain of E. coli than the one employed in 
the present experiments. Furthermore, it has been shown by 
Cohn and Morse (1959), in the case of staphylococci, that 
strain variation influences the ability of the leucocyte to 
kill ingested organisms.
It has been shown by Myrvik, et al. (1961a), Evans 
and Myrvik (1967) and Hirsch and Cohn (1960) that rabbit 
alveolar macrophages can be induced to a more active state. 
Such activated cells contain larger quantities of various 
catabolic enzymes, mitochondria, lysosomes, and other cells 
organelles. Activation of alveolar macrophages may be 
achieved by parenteral injection of endotoxin, gram negative 
bacteria, and BCG in oil. It is possible that cryptococcal 
cells are not killed by alveolar macrophages because the 
macrophages lack high levels of the necessary enzymes, i.e., 
they are not sufficiently activated.
An attempt was made to activate guinea pig alveolar 
macrophages by injecting animals with heated killed S. 
typhosa and S. marcescens. The results showed that a degree
77
of activation occurred as evidenced by an increase in enzyme 
levels (Table 2). However, when these activated alveolar 
macrophages were tested for their ability to kill C. neofor­
mans, they were found to be ineffective (Figures 5 and 6 ).
Phagocytosis of cryptococcal cells by human alveolar 
macrophages could not be demonstrated. It was hoped that 
collecting alveolar macrophages from a recently expired 
patient would yield healthy cells. The lungs used in these 
experiments were lavaged for alveolar macrophages 5 .0 hours 
postmortem. Only 40 per cent of the cells were viable and 
the percentage phagocytosis was very low. It seems quite 
certain that the low percentage of phagocytosis can be at­
tributed to lack of metabolic integrity. Cohen and Cline 
(1971) were able to culture human alveolar macrophages from 
fresh, surgically resected lungs. These cells were able to 
phagocytize heat killed C. albicans and viable Listeria 
monocytogenes. They were also able to kill the L. mono­
cytogenes , but not C. albicans blastospores.
It was interesting to note that the electron micro­
graphs showed that the alveolar macrophages from the first 
lavage appeared to be degenerated (Figure 7). These cells 
probably represent the so-called "dust cells" which are dy­
ing cells residing in the upper respiratory tract. From the 
second and third lavage of the lungs, cells were collected 
which had more typical morphology and which appeared to have 
a good complement of lysosomes (Figure 8 ). These were the
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cells used in all jjn vitro phagocytosis and fate experiments.
One of the objectives of these experiments was to 
observe the ultrastructure of cryptococcal cells after they 
had been incubated with guinea pig alveolar macrophages. 
Examination of an engulfed, budding cryptococcal cell showed 
that the cell was probably alive and was situated in a phago­
cytic vesicle (Figure 10). Lysosomes could not be found 
near the phagocytic vesicle. It is difficult to know how 
long the cell had been in the phagocyte, but it is tempting 
to conclude that, in response to C. neoformans, the lyso­
somes do not empty their enzymes into the phagocytic vesicle.
In preparation for vivo fate experiments, it was 
necessary to devise a medium which would support growth of 
large quantities of small (less than 5.0 y) non-encapsulated 
cells of C. neoformans. Farhi (1969) showed that a high 
concentration of a salt (NaNOg) in liquid medium would pro­
duce a cryptococcal cell with little or no capsule. A medium 
was therefore devised based on results obtained with dif­
ferent concentrations of NaNOg, glucose, peptone, yeast ex­
tract, and K 2HPO4 . This medium produced the desired results, 
although it is difficult to speculate on why a basic medium 
containing peptone, 50 mg K 2HPO4 /IOO ml, and no glucose 
yielded the best result (Table 5). It is possible that the 
glucose could be used directly in synthesis of capsule, how­
ever the coinbination of peptone and K 2HPO4 was merely empir­
ical.
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Using cryptococcal cells grown in the special medium^ 
an attempt was made to aerosolize the cells so that they 
could be inhaled into the lungs of guinea pigs. Even though 
large numbers of small cells (5.0 vi) were nebulized in the 
Tri-R Infection Apparatus, only a very few were retained by 
the guinea pig lungs. It is possible that the yeast cells 
were too large to enter the respiratory tract of the animals, 
thus accounting for the lower viable counts than were ex­
pected. Alternately, it could be concluded, however, that 
the cells were inhaled and immediately killed. If this hypo­
thesis were true, one would expect to see a high radioac­
tivity count in the lung tissue, since the cells were labeled 
with 32p. This was not the case, since very little radio­
activity was detected in the homogenized lungs. It is pos­
sible that, when the cryptococcal cells were nebulized, they 
picked up a film of water, or adhered together, which would 
have increased their size to greater than 5.0 y. It has been 
shown by Hatch (1961) that particles must be less than 5.0 y 
in diameter to reach the alveoli. Moreover, since the. aero­
dynamic qualities of a particle include not only diameter, 
but also the density and shape, hence the measurement of a 
particle under the microscope provides insufficient informa­
tion to predict its airborne behavior.
Since aerosolized cryptococcal cells could not be 
detected in adequate numbers in the lungs of guinea pigs, 
an alternate method was instituted. This method involved
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instillation of fairly large numbers of non-encapsulated 
cells directly into the lungs of guinea pigs by way of the 
trachea. A small amount of air was also injected with the 
cells to help force the material directly into the bronchi 
and on to the alveoli. Results showed that large numbers 
of 32p labeled cryptococcal cells were deposited in the 
lungs. In these experiments, the cryptococcal cells were 
not killed after 6.0 hours. Since the radioactivity re­
mained high in the lung tissue, the cells apparently re­
mained in the lungs (Figures 11 and 12). From this, it can 
be concluded that C. neoformans is not cleared from guinea 
pig lungs and is not killed after coming in contact with the 
lung milieu in the time period tested. Although the method 
of deposition used in these experiments was not as natural 
as voluntary inhalation, it did overcome the aerosol dynamics 
problem.
Myeloperoxidase (MPO), in combination with a halide 
and H 2 O 2 , has been shown to be an effective bactericidal and 
fungicidal element (Klebanoff, 1968; Lehrer, 1969; Lehrer 
and Cline, 1969). It was decided, therefore, to determine 
whether C. neoformans can be killed by the myeloperoxidase 
system. The first experiments showed that the combination 
of myeloperoxidase-NaI-H2 0 2  could kill C. neoformans in vitro 
(Table 8 ). Because MPO systems were known to kill C. albi­
cans , other Candida spp., Saccharomyces cerevisiae, Rhodo- 
torula spp., Geotrichum candidum, Aspergillus fumigatus,
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and A. niger, it was decided to test the system with C. albi­
cans. S. schenckii and R. oryzae were also tested in the 
MPO system. As was expected, the MPO system killed C. albi­
cans and S. schenckii. MPO did not kill R. oryzae, however, 
thus indicating that not all fungi are killed by the MPO 
system (Table 8 ).
It required several trials to find the optimal con­
centrations of components that could be used for testing the 
MPO system ^  vitro. If too high a concentration of either 
Nal or H 2 O 2 were used cryptococcal cells were killed in the 
absence of myeloperoxidase. Klebanoff (1965) was able to 
substitute NaCl for Nal as the halide in the MPO system and 
retain killing of E. coli. In the concentrations used in the 
present studies, it appeared that the same was true for C. 
neoformans; however examination of the data (Table 8 ) re­
vealed that the concentration of H 2O 2 was too high and was 
causing cell death by itself. When the concentration of 
H 2 O 2 was adjusted (Table 10) it was found that NaCl could 
not be substituted for Nal in the MPO system.
Overall, it can be concluded that (1) MP0 -H2 0 2 ~NaI 
kills encapsulated and non-encapsulated C. neoformans equal­
ly well (Tables 9 and 10), (2) combinations of the other com­
ponents alone or mixed did not kill C. neoformans appreci­
ably, (3) KCN and 3AT, at the molar concentrations used, in­
hibited the MP0 -NaI-H2 0 2  system (Tables 11 and 12), and (4) 
lower (44 units) levels of MPO were as effective in killing
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as higher (150 and 470 units) levels (Tables 8 , 11 and 12).
Although it is agreed by most researchers that myelo­
peroxidase systems are probably antimicrobial, the mechanism 
of this reaction is not clear. Some investigators feel that 
iodination of the microorganism is responsible, but this has 
not been shown conclusively (Klebanoff and Hamon, 1972). 
Others feel that chloride is the major halide ion involved 
which results in the formation of an aldehyde (Zglicynski, 
Stelmaszynska, Ostrowski, Naskalski, and Sznajd, 1968;
Sbarra, Paul, Jacobs, Strauss and Mitchell, 1972a). Most 
workers do not agree on the levels of halide and H 2 O 2 pre­
sent in the phagocyte, nor do they agree that these levels 
would be attainable in the normal ^  vivo situation (Kle­
banoff and Hamon, 1972; Sbarra, et ^ . , 1972b).
If a myeloperoxidase system is operative in alveo­
lar macrophages, it would seem that cryptococcal cells would 
be killed after phagocytosis. Examination of the data 
(Figure 13) revealed that extracts from guinea pig alveolar 
macrophages lacked myeloperoxidase, while extracts from 
human peripheral leucocytes yielded high quantities of MPO. 
Human alveolar macrophages seemed to have MPO activity, but 
the extracts were contaminated with PMN's and RBC's, known 
to be rich in peroxidases. Cohen and Cline (1971) have 
shown, by chemical stain only, that human alveolar macro­
phages lack myeloperoxidase.
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If alveolar macrophages truely lack MPO, it would be 
tempting to conclude that C. neoformans is not killed by 
these cells because they lack an MPO system. It should be 
emphasized, however, that MPO is not the only antimicrobial 
system, as pointed out earlier in the manuscript. Recently, 
Lehrer (1972) has described a candidicidal mechanism in 
neutrophils of subjects with hereditary myeloperoxidase 
deficiency. This system seems to operate independently of 
MPO, iodination, or the direct effect of H 2 O2 .
CHAPTER V 
SUMMARY
In vitro phagocytosis studies indicated that 
guinea pig alveolar macrophages could phagocytize, but not 
kill engulfed non-encapsulated cells of C. neoformans. 
Phagocytosis was shown to be inhibited by as little as 
100 ug/ml of cryptococcal capsule material. Activated 
macrophages were unable to kill engulfed cryptococcal cells 
after 4.0 hours incubation ^  vitro. Fate studies conducted 
with intact animals indicated that their lungs were incap­
able of clearing 32p_iabeled non-encapsulated C. neoformans 
after 6.0 hours. The lungs also lacked the ability to kill 
the cryptococcal cells after transtracheal instillation.
Myeloperoxidase (MPO) extracted from human poly­
morphonuclear leucocytes was effective in killing C. neo­
formans when coupled with sodium iodide and hydrogen per­
oxide in the proper concentrations. Inhibition of the MPO 
system was accomplished by treatment with potassium cyanide, 
3-amino triazole, or heat. Attempts to substitute sodium
chloride for sodium iodide in the MPO system failed.
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Myeloperoxidase activity was demonstrated in ex­
tracts from human polymorphonuclear leucocytes. MPO 
activity could not be detected in extracts from human and 
guinea pig alveolar macrophages.
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